A new name for the Kantify AI platform for drug discovery

Kantify shares the new name for its AI platform for small molecule and target discovery
Wed 24 Jul 2024

A new name for our AI powered drug discovery platform.

For a while now, we have felt that the former name of our AI platform Zeptomics did not fully illustrate how powerful and disruptive our AI technology is. It was therefore time for a new name which is shorter, easier to remember and - more importantly - which evokes intelligence.

We are very pleased to announce today that "Sapian" is the new name of our Artificial Intelligence platform for drug discovery.

Why Sapian?

The name "Sapian" is derived from "Sapiens," reflecting the platform's emphasis on intelligence and advanced predictive capabilities. "Sapiens," from the Latin "sapere," means "to be wise" or "to know," and is famously associated with "Homo sapiens," the species name for humans, signifying our unique intellectual abilities.

By naming our AI platform Sapian, we want to underscore how we combine human-like wisdom and advanced artificial intelligence to accelerate the discovery of targets and drugs even faster, for the benefit of patients.

What are our ambitions with Sapian ?

With the results which we have seen over the past months, we believe that Sapian is much more than a technology. It is a powerful tool to revolutionize drug discovery and make treatments available for patients, faster.

This is what we stand for, and we hope that you follow us in this journey!